Detalles de la búsqueda
1.
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Lancet;
403(10422): 171-182, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104577
2.
Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non-small cell lung cancer radiotherapy.
J Appl Clin Med Phys;
22(2): 42-48, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33492763
3.
Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Acta Oncol;
59(2): 164-170, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31608751
4.
Postoperative Radiation Therapy for Thymic Carcinoma: An Analysis of the International Thymic Malignancy Interest Group/European Society of Thoracic Surgeons Database.
J Thorac Oncol;
19(4): 626-635, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070599
5.
Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation Therapy.
Adv Radiat Oncol;
9(1): 101284, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38260213
6.
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
J Nucl Med;
65(4): 520-526, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485270
7.
Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
Radiother Oncol;
191: 110057, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104783
8.
Stereotactic body proton therapy for non-small cell lung cancer: Clinical indications and recommendations.
J Radiosurg SBRT;
9(1): 17-32, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029014
9.
Advances in treatment planning and management for the safety and accuracy of lung stereotactic body radiation therapy using proton pencil beam scanning: Simulation, planning, quality assurance, and delivery recommendations.
J Radiosurg SBRT;
9(1): 53-62, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029008
10.
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer.
Phys Imaging Radiat Oncol;
25: 100410, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36687507
11.
Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors.
J Radiosurg SBRT;
9(1): 63-74, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029007
12.
Stereotactic body radiation therapy for sarcoma pulmonary metastases.
Radiother Oncol;
187: 109824, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532104
13.
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial.
Int J Radiat Oncol Biol Phys;
2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38154510
14.
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.
JTO Clin Res Rep;
4(1): 100440, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36590015
15.
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.
Int J Radiat Oncol Biol Phys;
116(5): 1091-1099, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889516
16.
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol;
13: 1253629, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795442
17.
A Planning Comparison of IMRT vs. Pencil Beam Scanning for Deep Inspiration Breath Hold Lung Cancers.
Med Dosim;
47(1): 26-31, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426041
18.
Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys;
113(2): 335-344, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157996
19.
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.
Radiother Oncol;
167: 158-164, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34942280
20.
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers.
JCO Precis Oncol;
6: e2200024, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201714